The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2010

Filed:

Jun. 11, 2007
Applicants:

Jay Marshall Feingold, Wynnewood, PA (US);

Matthew L. Sherman, Newton, MA (US);

Lance H. Leopold, Dresher, PA (US);

Mark Berger, Merion Station, PA (US);

Inventors:

Jay Marshall Feingold, Wynnewood, PA (US);

Matthew L. Sherman, Newton, MA (US);

Lance H. Leopold, Dresher, PA (US);

Mark Berger, Merion Station, PA (US);

Assignee:

Wyeth LLC, Madison, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01);
U.S. Cl.
CPC ...
Abstract

Methods of treatment and pharmaceutical combinations are provided for the treatment of acute leukemia, such as acute myelogenous leukemia, and myelodysplastic syndrome. The methods of treatment and pharmaceutical combinations employ an anti-CD33 cytotoxic conjugate in combination with at least one compound selected from the group consisting of an anthracycline and a pyrimidine or purine nucleoside analog. Preferred methods of treatment and pharmaceutical combinations employ gemtuzumab ozogamicin, daunorubicin, and cytarabine.


Find Patent Forward Citations

Loading…